AVDL
Avadel Pharm Sp ADR

3,509
Mkt Cap
$1.8B
Volume
3.55M
52W High
$18.65
52W Low
$6.38
PE Ratio
-562.42
AVDL Fundamentals
Price
$18.56
Prev Close
$18.56
Open
$18.54
50D MA
$15.29
Beta
0.91
Avg. Volume
1.49M
EPS (Annual)
-$0.5133
P/B
19.80
Rev/Employee
$899,558.51
Loading...
Loading...
News
all
press releases
ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition
Alkermes inks $2.1B deal to acquire Avadel, adding the latter's Lumryz and new growth potential to its portfolio.
Zacks·3d ago
News Placeholder
More News
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel...
PR Newswire·4d ago
News Placeholder
Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Avadel Pharmaceuticals plc (NasdaqGM: AVDL) to...
Business Wire·4d ago
News Placeholder
HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM
HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND...
PR Newswire·4d ago
News Placeholder
Avadel Stock Rises After Acquisition Offer By Alkermes
Stocktwits·4d ago
News Placeholder
AVDL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avadel Pharmaceuticals plc Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avadel Pharmaceuticals plc (NASDAQ: AVDL) to Alkermes plc is fair to Avadel shareholders. Under the terms of the...
Business Wire·4d ago
News Placeholder
Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc PR Newswire DUBLIN, Oct. 22, 2025 NOT FOR RELEASE...
PR Newswire·4d ago
News Placeholder
SKYE Stock Plunges 60% as Obesity Candidate Misses Key Phase II Goal
Skye Bioscience stock nosedives 60% after its investigational obesity candidate, nimacimab, fails to meet the key goal in a mid-stage study.
Zacks·19d ago
News Placeholder
ESPR Settles Nexletol/Nexlizet Patent Litigation With RDY, Stock Up
Esperion settles Nexletol and Nexlizet patent dispute with Dr. Reddy's, securing U.S. market exclusivity until 2040 and lifting its shares nearly 14%.
Zacks·20d ago
News Placeholder
Encompass Health Opens First Connecticut Rehab Hospital in Danbury
EHC opens its first Connecticut rehab hospital in Danbury, boosting its nationwide expansion and meeting rising demand for specialized care.
Zacks·1mo ago

Latest AVDL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.